FDA Greenlights Drugs to Battle Screwworms in Cats and Dogs
Published Date: 12/29/2025
Notice
Summary
The FDA just gave the green light for two new emergency animal drugs to treat nasty New World screwworm infections in dogs, puppies, cats, and kittens. These quick-acting treatments are now officially authorized as of late 2025 to help protect pets from this serious health threat. Pet owners and vets can expect faster access to these lifesaving drugs without extra costs right now.
Analyzed Economic Effects
3 provisions identified: 3 benefits, 0 costs, 0 mixed.
EUA for Dog Screwworm Treatment
The FDA issued an Emergency Use Authorization (EUA) to Elanco US Inc. for Credelio (lotilaner) to treat New World screwworm (NWS) infestations in dogs and puppies. This authorization is effective October 24, 2025 and allows emergency use and introduction into interstate commerce under the FD&C Act section 564.
EUA for Cat Screwworm Treatment
The FDA issued an Emergency Use Authorization (EUA) to Elanco US Inc. for Credelio CAT (lotaliner) to treat New World screwworm (NWS) infestations in cats and kittens. This authorization is effective November 21, 2025 and allows emergency use and introduction into interstate commerce under the FD&C Act section 564.
Faster Access to Pet Treatments Now
The notice states that pet owners and veterinarians can expect faster access to these lifesaving drugs for New World screwworm and that this access is available without extra costs right now. The two EUAs became effective October 24, 2025 and November 21, 2025, respectively.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-09767 — Oscar Bobo: Final Debarment Order
Oscar Bobo is officially banned for 5 years from importing any drugs into the U.S. because he repeatedly brought in mislabeled medicines that don’t follow FDA rules. He ignored the chance to defend himself, so the ban started on May 15, 2026. This means no drug imports from him for a while, but he can apply to end the ban anytime if he meets FDA’s conditions.
2026-09448 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; The Real Cost Campaign Outcomes Evaluation Study: Cohort 3
The FDA is asking for approval to collect info for the third group in its Real Cost Campaign, which teaches kids about the dangers of tobacco. This helps the FDA improve its anti-smoking messages and protect young people’s health. Comments on this info collection are open until June 12, 2026, with no new costs for participants.
2026-09543 — Agency Information Collection Activities; Proposed Collection; Comment Request; Postmarketing Adverse Experience Reporting
The FDA wants your thoughts on how drug companies report problems after their products hit the market. This affects drug makers and healthcare folks who keep track of side effects. They’re asking for comments by July 13, 2026, to help improve the process without adding extra costs or paperwork.
2026-09544 — Modified Risk Tobacco Product Application: Renewal Applications for VLN® King and VLN® Menthol King, Cigarette Products Submitted by 22nd Century Group Inc.
The FDA is inviting the public to comment on the renewal of special approval for two cigarette products by 22nd Century Group Inc. These products claim to lower health risks compared to regular cigarettes. If approved, the renewal keeps these products on the market with their modified risk status, affecting smokers and the tobacco industry starting May 13, 2026.
2026-09335 — Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect and Identify Microorganism Nucleic Acids and Resistance Markers From Patients With Suspected Orthopedic Infection
Hey there! This update is all about a new medical device that helps doctors quickly find germs and their resistance traits in people who might have bone infections. It affects hospitals and labs by officially classifying this device, making it easier and faster to diagnose tough infections. The change kicks in soon, helping patients get the right treatment without delay—and it could save money by avoiding wrong meds!
2026-09368 — Enforcement Priorities for Certain New Tobacco Products Marketed Without Premarket Authorization; Guidance for Industry; Availability
The FDA is setting clear rules for certain new tobacco products like e-cigarettes and nicotine pouches that don’t have official approval yet. Companies selling these products without permission might face enforcement actions starting now, so they need to get authorized or risk penalties. This helps protect public health and keeps the market fair and safe.
Previous / Next Documents
Previous: 2025-23913 — Carbon and Certain Alloy Steel Wire Rod From China; Determinations
The U.S. government decided to keep special taxes on carbon and certain alloy steel wire rod imported from China because removing them could hurt American steel makers. These taxes help protect U.S. jobs and businesses from unfair competition. This decision was finalized at the end of 2025 and means importers will keep paying these extra fees for now.
Next: 2025-23952 — Sunshine Act Meetings
The National Council on Disability is holding a two-day meeting in January 2026, both in Orlando and online, to discuss important issues like youth in nursing homes, disaster experiences, and accessible transportation. This meeting affects people with disabilities, especially in Florida, and aims to improve policies and services. No new costs are mentioned, but the event invites public input and shares updates on ongoing projects.